Early research (Phase 1)Study completedNCT01066390
What this trial is testing
A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma
Who this might be right for
Melanoma
Bart Neyns 18